Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
<h4>Background</h4>Patients with chronic lymphocytic leukemia and 13q deletion as their only FISH abnormality could have a different outcome depending on the number of cells displaying this aberration. Thus, cases with a high number of 13q- cells (13q-H) had both shorter overall survival...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c161b0b94cb74f61ad313f1a2d603024 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c161b0b94cb74f61ad313f1a2d603024 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c161b0b94cb74f61ad313f1a2d6030242021-11-18T08:09:02ZMolecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.1932-620310.1371/journal.pone.0048485https://doaj.org/article/c161b0b94cb74f61ad313f1a2d6030242012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23152777/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Patients with chronic lymphocytic leukemia and 13q deletion as their only FISH abnormality could have a different outcome depending on the number of cells displaying this aberration. Thus, cases with a high number of 13q- cells (13q-H) had both shorter overall survival and time to first therapy. The goal of the study was to analyze the genetic profile of 13q-H patients.<h4>Design and methods</h4>A total of 102 samples were studied, 32 of which served as a validation cohort and five were healthy donors.<h4>Results</h4>Chronic lymphocytic leukemia patients with higher percentages of 13q- cells (>80%) showed a different level of gene expression as compared to patients with lower percentages (<80%, 13q-L). This deregulation affected genes involved in apoptosis and proliferation (BCR and NFkB signaling), leading to increased proliferation and decreased apoptosis in 13q-H patients. Deregulation of several microRNAs, such as miR-15a, miR-155, miR-29a and miR-223, was also observed in these patients. In addition, our study also suggests that the gene expression pattern of 13q-H cases could be similar to the patients with 11q- or 17p-.<h4>Conclusions</h4>This study provides new evidence regarding the heterogeneity of 13q deletion in chronic lymphocytic leukemia patients, showing that apoptosis, proliferation as well as miRNA regulation are involved in cases with higher percentages of 13q- cells.Ana Eugenia RodríguezJose Ángel HernándezRocío BenitoNorma C GutiérrezJuan Luis GarcíaMaría Hernández-SánchezAlberto RisueñoM Eugenia SarasqueteEncarna FermiñánRosa FisacAlfonso García de CocaGuillermo Martín-NúñezNatalia de Las HerasIsabel RecioOliver GutiérrezJavier De Las RivasMarcos GonzálezJesús M Hernández-RivasJesús M Hernández-RivasPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 11, p e48485 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Ana Eugenia Rodríguez Jose Ángel Hernández Rocío Benito Norma C Gutiérrez Juan Luis García María Hernández-Sánchez Alberto Risueño M Eugenia Sarasquete Encarna Fermiñán Rosa Fisac Alfonso García de Coca Guillermo Martín-Núñez Natalia de Las Heras Isabel Recio Oliver Gutiérrez Javier De Las Rivas Marcos González Jesús M Hernández-Rivas Jesús M Hernández-Rivas Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14. |
description |
<h4>Background</h4>Patients with chronic lymphocytic leukemia and 13q deletion as their only FISH abnormality could have a different outcome depending on the number of cells displaying this aberration. Thus, cases with a high number of 13q- cells (13q-H) had both shorter overall survival and time to first therapy. The goal of the study was to analyze the genetic profile of 13q-H patients.<h4>Design and methods</h4>A total of 102 samples were studied, 32 of which served as a validation cohort and five were healthy donors.<h4>Results</h4>Chronic lymphocytic leukemia patients with higher percentages of 13q- cells (>80%) showed a different level of gene expression as compared to patients with lower percentages (<80%, 13q-L). This deregulation affected genes involved in apoptosis and proliferation (BCR and NFkB signaling), leading to increased proliferation and decreased apoptosis in 13q-H patients. Deregulation of several microRNAs, such as miR-15a, miR-155, miR-29a and miR-223, was also observed in these patients. In addition, our study also suggests that the gene expression pattern of 13q-H cases could be similar to the patients with 11q- or 17p-.<h4>Conclusions</h4>This study provides new evidence regarding the heterogeneity of 13q deletion in chronic lymphocytic leukemia patients, showing that apoptosis, proliferation as well as miRNA regulation are involved in cases with higher percentages of 13q- cells. |
format |
article |
author |
Ana Eugenia Rodríguez Jose Ángel Hernández Rocío Benito Norma C Gutiérrez Juan Luis García María Hernández-Sánchez Alberto Risueño M Eugenia Sarasquete Encarna Fermiñán Rosa Fisac Alfonso García de Coca Guillermo Martín-Núñez Natalia de Las Heras Isabel Recio Oliver Gutiérrez Javier De Las Rivas Marcos González Jesús M Hernández-Rivas Jesús M Hernández-Rivas |
author_facet |
Ana Eugenia Rodríguez Jose Ángel Hernández Rocío Benito Norma C Gutiérrez Juan Luis García María Hernández-Sánchez Alberto Risueño M Eugenia Sarasquete Encarna Fermiñán Rosa Fisac Alfonso García de Coca Guillermo Martín-Núñez Natalia de Las Heras Isabel Recio Oliver Gutiérrez Javier De Las Rivas Marcos González Jesús M Hernández-Rivas Jesús M Hernández-Rivas |
author_sort |
Ana Eugenia Rodríguez |
title |
Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14. |
title_short |
Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14. |
title_full |
Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14. |
title_fullStr |
Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14. |
title_full_unstemmed |
Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14. |
title_sort |
molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2012 |
url |
https://doaj.org/article/c161b0b94cb74f61ad313f1a2d603024 |
work_keys_str_mv |
AT anaeugeniarodriguez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT joseangelhernandez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT rociobenito molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT normacgutierrez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT juanluisgarcia molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT mariahernandezsanchez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT albertorisueno molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT meugeniasarasquete molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT encarnaferminan molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT rosafisac molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT alfonsogarciadecoca molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT guillermomartinnunez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT nataliadelasheras molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT isabelrecio molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT olivergutierrez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT javierdelasrivas molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT marcosgonzalez molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT jesusmhernandezrivas molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 AT jesusmhernandezrivas molecularcharacterizationofchroniclymphocyticleukemiapatientswithahighnumberoflossesin13q14 |
_version_ |
1718422192003219456 |